Special review articleToward a biaxial model of “bipolar” affective disorders: Spectrum phenotypes as the products of neuroelectrical and neurochemical alterations
Introduction
Bipolar disorder represents a leading cause of disability worldwide (Murray and Lopez, 1996), and innovative treatments are urgently required. In addition to the extraordinarily high rates of suicide (Angst et al., 2002, Rihmer and Kiss, 2002), and suicide attempts (Davidson et al., 2002) relative to the general or other mentally ill populations, the amount of time spent ill, severity of illness, rates of comorbidity (McElroy et al., 2001) psychosocial impairment (Judd and Akiskal, 2003) and stigmatization (Morselli et al., 2004) have a tremendous impact on quality of life. Additionally, depressive, subsyndromal and interepisode morbidity are often exacerbated by under- or late diagnosis (Ghaemi et al., 2001, Ghaemi et al., 2002). Development of more effective preventive, acute and maintenance treatments requires synthesis of the ever-expanding body of research findings.
It is critical that any such synthesis meets the important general criteria of causal inference (Bradford-Hill, 1966), particularly testability. Summarizing recommendations from researchers in the field, future hypotheses must: 1) consider molecular candidates–in addition to those involved in neurochemical transduction–that are localized within neuronal membranes, in a widely-distributed system likely responsible for stimulus gating, and subserving integrated cognitive, emotional and motoric functioning (Goodwin and Jamison, 1990, pp. 593–594); and 2) address neurobiology at the molecular, cellular, and systems levels, that is manifested in the behavioral expression of unstable, episodic and progressive illness (Manji and Lenox, 2000, p.518). This paper addresses these imperatives.
Section snippets
Historical background: defining essential traits in affective disorders
Years of phenomenologic observations have produced an array of illness conceptualizations and nosologies attempting to address the question of whether clinically-distinct affective subtypes are different manifestations of a common pathophysiology or derive from unique etiologic sources. After several decades (1883–1920) of clinical observation, Kraepelin ultimately described a broad spectrum of phenomenology that encompassed all observed illness forms. In contrast, Carl Wernicke advocated for
Theoretical background: deriving affective pathophysiologic hypotheses
Current pathophysiologic hypotheses attempting to explain these observations posit explanations at the cellular level and may fall into three general categories: 1) electrical signaling (especially presynaptic), 2) parasynaptic neurotransmitter–receptor signaling systems (first messenger), and 3) post-receptor neurochemical signaling systems (second and third messenger).
The latter two subcellular systems have received significant attention in recent decades. Research into the potential
The biaxial model
The biaxial model offers a new conceptualization of genetic, cellular, system and behavioral level bases of affective functioning and disease (see Fig. 1, Fig. 2). Moreover, by distinguishing between individual- and population-level effects, at each of the four neurobiological levels, the model provides an explanation and a new lens for interpretation of the widespread inconsistencies across studies.
In summary, the biaxial model proposes that: 1) of the 10,000+ neuronally-expressed genes, the
Evidence in the pathophysiology of affective disorders
The ultimate validation of this hypothesis will be the prospective demonstration of proposed biaxial genetic alterations, their impact on corresponding proteomic complements, system functioning, and phenotypic correlation. Nonetheless, a wealth of data at all four levels is very consistent with the biaxial hypothesis.
Genetic studies
Rapidly evolving technologies, such as DNA chip/array sequencing platforms (Mir and Southern, 2000, Califano et al., 2000), can be applied on a large scale, to identify and sequence polymorphic variations across neuroelectrical genes, which can then be used in linkage analyses and as screening markers in genome-wide associational studies. Building upon systems biology theory (Aderem, 2005), a database (currently under development) in which all potentially relevant genes, are classified
Conclusions
Current evidence does not support an exclusive pathophysiologic role for neurochemical alterations in affective disorders. A high degree of inconsistency is found across published investigations; most positive studies to date are insufficient to support more than system-level neurochemical alterations; and those genetic studies suggesting an etiologic connection in ‘bipolar’ subjects to neurochemical systems apply to narrow phenotypic subsets.
Although a few genetic studies have
References (138)
Systems biology: its practice and challenges
Cell
(2005)Validating ‘hard’ and ‘soft’ phenotypes within the bipolar spectrum: continuity or discontinuity?
Journal of Affective Disorders
(2003)- et al.
The evolving bipolar spectrum. Prototypes I, II, III, and IV
Psychiatric Clinics Of North America
(1999) - et al.
Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders
Journal of Affective Disorders
(2000) - et al.
Proposed multidimensional structure of mania: beyond the euphoric–dysphoric dichotomy
Journal of Affective Disorders
(2003) - et al.
Validating antidepressant-associated hypomania (bipolar III) a systematic comparison with spontaneous hypomania (bipolar II)
Journal of Affective Disorders
(2003) - et al.
Bipolarity from ancient to modern times: conception, birth and rebirth
Journal of Affective Disorders
(2001) - et al.
Mortality of patients with mood disorders: follow-up over 34–38 years
Journal of Affective Disorders
(2002) Toward a biaxial model of “bipolar” affective disorders: further exploration of genetic, molecular and cellular substrates
Journal of Affective Disorders
(2006)- et al.
Genome scan for susceptibility loci for schizophrenia and bipolar disorder
Biological Psychiatry
(2002)
Highly recurrent unipolar may be related to bipolar II
Comprehensive Psychiatry
Role of sodium and potassium ions in storage of norepinephrine by sympathetic nerve endings
Life Science
The bipolar spectrum: a clinical reality in search of diagnostic criteria and an assessment methodology
Journal of Affective Disorders
The Na, K-ATPase hypothesis for bipolar illness
Biological Psychiatry
A genome-wide scan of symptom dimensions in bipolar disorder pedigrees of adult probands
Journal of Affective Disorders
Is there progression from irritability/dyscontrol to major depressive and manic symptoms? A retrospective community survey of parents of bipolar children
Journal of Affective Disorders
Circadian rhythms, multilevel models of emotion and bipolar disorder—an initial step towards integration
Clinical Psychology Review
The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases
Journal of Affective Disorders
A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities
Neuroscience
Trinucleotide repeat expansion in the beta1 subunit of the sodium pump in manic-depression illness: a negative study
Journal of Affective Disorders
Differential interaction of anaesthetics and antiepileptic drugs with neuronal Na+ channels, Ca2+ channels and GABAA receptors
British Journal of Anaesthesia
Serotonin and bipolar disorder
Journal of Affective Disorders
Molecular diversity of voltage-gated sodium channel alpha subunits expressed in neuronal and non-neuronal excitable cells
Neuroscience
Is there a specific membrane deffect in bipolar disorders?
Biological Psychiatry
Evidence for an allelic association between bipolar disorder and a Na+, K+ adenosine triphosphatase α subunit gene (ATP1A3)
Biological Psychiatry
Action potential conduction speed and dyscorrelation, affective disorders and the influence of n-3 essential fatty acids
Medical Hypotheses
The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV
Journal of Clinical Psychopharmacology
Depressive disorders: toward a unified hypothesis
Science
The bipolar spectrum—the shaping of a new paradigm in psychiatry
Current Psychiatry Reports
Psychopathologic correlates of suicidal ideation in major depressive outpatients: is it all due to unrecognized (bipolar) depressive mixed states?
Psychopathology
Criteria for the “soft” bipolar spectrum: treatment implications
Psychopharmacology Bulletin
Switching from ‘unipolar’ to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients
Archives of General Psychiatry
Diagnostic and Statistical Manual of Mental Disorders
A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders
Molecular Psychiatry
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Science
Linkage of bipolar affective disorder on chromosome 8q24: follow-up and parametric analysis
Molecular Psychiatry
A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19
Molecular Psychiatry
Brain complexity increases in mania
Neuroreport
Lamotrigine as an augmentation agent in treatment-resistant depression
Journal of Clinical Psychiatry
A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes
Journal of Clinical Psychiatry
Is 4 days the minimum duration of hypomania in bipolar II disorder?
European Archives of Psychiatry and Clinical Neuroscience
Unipolar depression with bipolar family history: links with the bipolar spectrum
Psychiatry and Clinical Neurosciences
Toward better probing for hypomania of bipolar-II disorder by using Angst's checklist
International Journal of Methods in Psychiatric Research.
The neurobiology of bipolar disorder
American Journal of Medical Genetics Part C (Semin Medical Genet)
Molecular linkage studies of bipolar disorders
Bipolar Disorders
Small conductance Ca2+-activated K+ channels as targets of CNS drug development
Current Drug Targets. CNS and Neurological Disorders
The environment and disease: association or causation?
Proceedings of the Royal Society of Medicine
The “switch process” in manic-depressive illness. 3. Theoretical implications
Archives of General Psychiatry
Analysis of gene expression microarrays for phenotype classification
Proceedings (International Conference on Intelligent Systems for Molecular Biology)
Cited by (16)
Lithium modulates cortical excitability in vitro
2010, Brain ResearchCitation Excerpt :Bipolar disorder is a heritable, chronic, periodic disturbance of function in an electrically excitable tissue, and as such it has the characteristics of an ion channel disease (Gargus, 2006; Askland, 2006; Askland and Parsons, 2006). Extensive genetic association studies (Askland and Parsons, 2006; Askland, 2006; The Welcome Trust Case Control Consortium, 2007; Askland et al., 2009) conclude that bipolar disorder may result from altered expression of membrane ion channels in brain neurons. Antiepileptic drugs acting on ion channels are commonly used to treat bipolar disorder (Gargus, 2006, Rogawski and Loscher, 2004b), for which they are the only established alternative to Li+.
Tryptophan breakdown pathway in bipolar mania
2007, Journal of Affective DisordersToward a biaxial model of "bipolar" affective disorders: Further exploration of genetic, molecular and cellular substrates
2006, Journal of Affective DisordersTryptophan Catabolites in Bipolar Disorder: A Meta-Analysis
2021, Frontiers in ImmunologyNeuropathology of Kynurenine Pathway of Tryptophan Metabolism
2020, Current Pharmacology Reports